SONALASENSE Trademark

Trademark Overview

On Tuesday, March 1, 2022, a trademark application was filed for SONALASENSE with the United States Patent and Trademark Office. The USPTO has given the SONALASENSE trademark a serial number of 97290254. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, October 29, 2024. This trademark is owned by SonALAsense, Inc.. The SONALASENSE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in combination therapy for the treatment of cancer
sonalasense

General Information

Serial Number97290254
Word MarkSONALASENSE
Filing DateTuesday, March 1, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Goods and Servicespharmaceutical preparations for use in combination therapy for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSonALAsense, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710
Party NameSonALAsense, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710

Trademark Events

Event DateEvent Description
Tuesday, December 13, 2022NON-FINAL ACTION E-MAILED
Friday, March 4, 2022NEW APPLICATION ENTERED
Friday, March 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2022ASSIGNED TO EXAMINER
Tuesday, December 13, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 8, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, March 8, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, April 10, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, April 10, 2023EXAMINERS AMENDMENT E-MAILED
Monday, April 10, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 10, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, April 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 27, 2023SOU EXTENSION 1 FILED
Wednesday, December 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 27, 2023SOU EXTENSION 1 GRANTED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU EXTENSION 3 FILED
Tuesday, October 29, 2024SOU EXTENSION 3 GRANTED
Friday, December 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024SOU EXTENSION 2 GRANTED
Thursday, June 27, 2024SOU EXTENSION 2 FILED

Related Keywords

sonalasense treatment cancer therapy combination preparations pharmaceutical